Preemptive therapy in nonneutropenic patients with Candida infection using the Japanese guidelines
- PMID: 17535843
- DOI: 10.1345/aph.1K010
Preemptive therapy in nonneutropenic patients with Candida infection using the Japanese guidelines
Abstract
Background: The Japanese Guidelines for the Diagnosis and Treatment of Deep-Seated Mycosis were established in 2003. Proven Candida infection (CI) is defined as at least one positive blood culture yielding a Candida species. Clinically documented CI requires documentation of more than 2 sites of colonization and a positive plasma beta-D-glucan test. Possible CI is diagnosed by one of the above criteria in febrile, nonneutropenic critically ill patients.
Objective: To assess the use of definitions of clinically documented and possible CI for guiding preemptive antifungal therapy in critically ill patients.
Methods: The patients treated in our intensive care unit (ICU) for at least 48 hours between 2000 and 2004 were investigated. The administration of antifungal agents and ICU mortality were compared among proven, clinically documented, and possible CI groups for age, sex, APACHE II score, diagnosis, length of ICU stay, treatment, number of colonization sites, and plasma beta-D-glucan level.
Results: Six patients were diagnosed with proven CI, 25 were diagnosed with clinically documented CI, and 104 with possible CI. The patients with clinically documented CI were compared with those with possible CI, and statistically significant differences were found in the following variables: APACHE II score (p = 0.018), length of ICU stay (p < 0.01), use of ventilator (p = 0.027), tracheotomy (p = 0.027), number of colonization sites (p < 0.001), plasma beta-D-glucan level (p < 0.001), and administration of antifungal agents (p < 0.001); incidence of mortality was not statistically significant (p = 0.33). The shorter length of ICU stay, use of ventilator, and continuous hemodiafiltration were risk factors for death after adjusting for APACHE II score, admission before/after 2003, antifungal therapy, and other factors. Although the frequency of the administration of preemptive antifungal therapy was higher after 2003 than before, the mortality rate did not differ significantly.
Conclusions: The use of the definitions of clinically documented and possible CI may be beneficial for determining when it is appropriate to initiate preemptive antifungal therapy. However, use of the guidelines did not lead to prevention of possible CI proceeding to clinically documented CI or to improved mortality.
Similar articles
-
Impact of fluconazole administration on outcomes in critically ill patients.Ann Pharmacother. 2004 Oct;38(10):1588-92. doi: 10.1345/aph.1D441. Epub 2004 Aug 31. Ann Pharmacother. 2004. PMID: 15340132
-
[Retrospective analysis of fluconazole efficacy in Candida-colonized, non-neutropenic, surgical patients in long-term intensive care].Dtsch Med Wochenschr. 2001 Aug 17;126(33):905-8. doi: 10.1055/s-2001-16501. Dtsch Med Wochenschr. 2001. PMID: 11514925 German.
-
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).Crit Care Med. 2009 May;37(5):1612-8. doi: 10.1097/CCM.0b013e31819efac0. Crit Care Med. 2009. PMID: 19325476
-
Candida prophylaxis and therapy in the ICU.Semin Respir Crit Care Med. 2011 Apr;32(2):159-73. doi: 10.1055/s-0031-1275528. Epub 2011 Apr 19. Semin Respir Crit Care Med. 2011. PMID: 21506052 Review.
-
Candida in the ICU.Clin Chest Med. 2009 Jun;30(2):287-93, vi-vii. doi: 10.1016/j.ccm.2009.02.013. Clin Chest Med. 2009. PMID: 19375635 Review.
Cited by
-
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.Intensive Care Med. 2019 Jun;45(6):789-805. doi: 10.1007/s00134-019-05599-w. Epub 2019 Mar 25. Intensive Care Med. 2019. PMID: 30911804
-
Biomarker-guided antifungal stewardship policies for patients with invasive candidiasis.Curr Med Mycol. 2018 Dec;4(4):37-44. doi: 10.18502/cmm.4.4.385. Curr Med Mycol. 2018. PMID: 30815616 Free PMC article. Review.
-
Antifungal clinical trials and guidelines: what we know and do not know.Cold Spring Harb Perspect Med. 2014 Nov 3;4(11):a019745. doi: 10.1101/cshperspect.a019745. Cold Spring Harb Perspect Med. 2014. PMID: 25368017 Free PMC article. Review.
-
Canadian practice guidelines for surgical intra-abdominal infections.Can J Infect Dis Med Microbiol. 2010 Spring;21(1):11-37. doi: 10.1155/2010/580340. Can J Infect Dis Med Microbiol. 2010. PMID: 21358883 Free PMC article. No abstract available.
-
Candida colonization and candiduria in critically ill patients in the intensive care unit.Drugs. 2009;69 Suppl 1:51-7. doi: 10.2165/11315640-000000000-00000. Drugs. 2009. PMID: 19877735 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical